title: The effect Akt2 deletion on tumor development in Pten(+/-) mice.
abstract: The serine/threonine kinase Akt is frequently activated in human cancers and is considered an attractive therapeutic target. However, the relative contributions of the different Akt isoforms to tumorigenesis, and the effect of their deficiencies on cancer development are not well understood. We had previously shown that Akt1 deficiency is sufficient to markedly reduce the incidence of tumors in Pten(+/-) mice. Particularly, Akt1 deficiency inhibits endometrial carcinoma and prostate neoplasia in Pten(+/-) mice. Here, we analyzed the effect of Akt2 deficiency on the incidence of tumors in Pten(+/-) mice. Relative to Akt1, Akt2 deficiency had little-to-no effect on the incidence of prostate neoplasia, endometrial carcinoma, intestinal polyps and adrenal lesions in Pten(+/-) mice. However, Akt2 deficiency significantly decreased the incidence of thyroid tumors in Pten(+/-), which correlates with the relatively high level of Akt2 expression in the thyroid. Thus, unlike Akt1 deletion, Akt2 deletion is not sufficient to markedly inhibit tumorigenesis in Pten(+/-) mice in most tested tissues. The relatively small effect of Akt2 deletion on the inhibition of tumorigenesis in Pten(+/-) mice could be explained, in part, by an insufficient decrease in total Akt activity, due to the relatively lower Akt2 versus Akt1 expression, and relatively high blood insulin levels in Pten(+/-)Akt2(-/-) mice. The relatively high blood insulin levels in Pten(+/-)Akt2(-/-) mice may elevate the activity of Akt1, and possibly Akt3, thus, limiting the reduction of total Akt activity and preventing this activity from dropping to a threshold level required to inhibit tumorigenesis.
authors: Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, IL 60607, USA.
authors: P-Z
authors: PZ
authors: Xu
authors: M-L
authors: ML
authors: Chen
authors: S-M
authors: SM
authors: Jeon
authors: X-d
authors: XD
authors: Peng
authors: N
authors: N
authors: Hay
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000209:etiology; D000818:Animals; D016889:Endometrial Neoplasms / Q000209:etiology; D005260:Female; D007328:Insulin / Q000097:blood; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000209:etiology* / Q000517:prevention & control; D051059:PTEN Phosphohydrolase / Q000502:physiology*; D019048:Prostatic Intraepithelial Neoplasia / Q000209:etiology; D011471:Prostatic Neoplasms / Q000209:etiology; D051057:Proto-Oncogene Proteins c-akt / Q000172:deficiency / Q000502:physiology*; D013964:Thyroid Neoplasms / Q000209:etiology
chemical_list: D007328:Insulin; C514862:Akt1 protein, mouse; C494922:Akt2 protein, mouse; D051057:Proto-Oncogene Proteins c-akt; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse